Agilent: Rising Short Base, Low Utilization

Agilent Technologies (A) is consolidating its position in the growing bio-analytics market through the purchase of medical software company Varian for $1.5bn. The short position is significant at 3.5% and has been increasing in recent weeks despite the rising share price.Utilization is low, with about 12% of the lendable actually out on loan.

Download the full report by clicking here.